[DPHARMA] QoQ Annualized Quarter Result on 31-Mar-2012 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
17-May-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
31-Mar-2012 [#1]
Profit Trend
QoQ- 0.48%
YoY- 13.23%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Revenue 135,310 133,242 140,824 144,228 138,132 140,128 136,658 -0.65%
PBT 35,298 35,064 35,812 35,476 34,728 35,856 34,332 1.85%
Tax -9,284 -8,374 -8,662 -8,644 -8,023 -8,686 -8,620 5.04%
NP 26,014 26,689 27,150 26,832 26,705 27,169 25,712 0.77%
-
NP to SH 26,014 26,689 27,150 26,832 26,705 27,169 25,712 0.77%
-
Tax Rate 26.30% 23.88% 24.19% 24.37% 23.10% 24.22% 25.11% -
Total Cost 109,296 106,553 113,674 117,396 111,427 112,958 110,946 -0.98%
-
Net Worth 169,354 167,965 162,400 170,824 163,783 162,405 154,105 6.46%
Dividend
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Div 19,434 - 9,716 - 24,983 - 9,718 58.39%
Div Payout % 74.71% - 35.79% - 93.56% - 37.80% -
Equity
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Net Worth 169,354 167,965 162,400 170,824 163,783 162,405 154,105 6.46%
NOSH 138,815 138,814 138,803 138,881 138,799 138,807 138,833 -0.00%
Ratio Analysis
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
NP Margin 19.23% 20.03% 19.28% 18.60% 19.33% 19.39% 18.81% -
ROE 15.36% 15.89% 16.72% 15.71% 16.31% 16.73% 16.68% -
Per Share
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
RPS 97.47 95.99 101.46 103.85 99.52 100.95 98.43 -0.64%
EPS 18.74 19.23 19.56 19.32 19.24 19.57 18.52 0.78%
DPS 14.00 0.00 7.00 0.00 18.00 0.00 7.00 58.40%
NAPS 1.22 1.21 1.17 1.23 1.18 1.17 1.11 6.47%
Adjusted Per Share Value based on latest NOSH - 138,881
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
RPS 14.07 13.85 14.64 14.99 14.36 14.57 14.21 -0.65%
EPS 2.70 2.77 2.82 2.79 2.78 2.82 2.67 0.74%
DPS 2.02 0.00 1.01 0.00 2.60 0.00 1.01 58.40%
NAPS 0.1761 0.1746 0.1688 0.1776 0.1703 0.1688 0.1602 6.48%
Price Multiplier on Financial Quarter End Date
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Date 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 30/09/11 30/06/11 -
Price 2.13 2.36 2.23 2.40 2.02 2.10 2.34 -
P/RPS 2.19 2.46 2.20 2.31 2.03 2.08 2.38 -5.37%
P/EPS 11.37 12.27 11.40 12.42 10.50 10.73 12.63 -6.73%
EY 8.80 8.15 8.77 8.05 9.52 9.32 7.91 7.33%
DY 6.57 0.00 3.14 0.00 8.91 0.00 2.99 68.61%
P/NAPS 1.75 1.95 1.91 1.95 1.71 1.79 2.11 -11.67%
Price Multiplier on Announcement Date
31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 CAGR
Date 25/02/13 23/11/12 16/08/12 17/05/12 22/02/12 21/11/11 18/08/11 -
Price 2.17 2.28 2.38 2.38 2.12 2.10 2.22 -
P/RPS 2.23 2.38 2.35 2.29 2.13 2.08 2.26 -0.88%
P/EPS 11.58 11.86 12.17 12.32 11.02 10.73 11.99 -2.28%
EY 8.64 8.43 8.22 8.12 9.08 9.32 8.34 2.37%
DY 6.45 0.00 2.94 0.00 8.49 0.00 3.15 60.90%
P/NAPS 1.78 1.88 2.03 1.93 1.80 1.79 2.00 -7.44%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment